Teva Pharmaceutical Industries Limited (TEVA) predicted -2.93% EPS growth for next year – Wallstreet Investorplace

Teva Pharmaceutical Industries Limited (TEVA) predicted -2.93% EPS growth for next year Wallstreet Investorplace

Teva Pharmaceutical Industries Limited (TEVA) projected to achieve earnings per share (EPS) growth of -26.90% for this year while EPS growth expected to …